Navigation Links
ERT Reports Second Quarter 2011 Operating Results
Date:8/1/2011

PHILADELPHIA, Aug. 1, 2011 /PRNewswire/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERT) a global technology-driven provider of services and customizable medical devices to biopharmaceutical and healthcare organizations and the market leader for centralized cardiac safety and respiratory efficacy services in drug development, announced today results for the second quarter ended June 30, 2011.  Unless otherwise noted, all comparative numbers refer to changes from the same period a year ago.  The financial results include the results related to CareFusion Research Services (RS and now included as part of our German operations) commencing from its date of acquisition on May 28, 2010.  

This press release contains financial measures prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and non-GAAP measures adjusted to exclude the impact of the amortization of the acquired intangibles and other assets and acquisition and other costs related to the RS acquisition and related income tax effects.  A reconciliation of these GAAP and non-GAAP measures is found in the attached "Reconciliation of GAAP to Non-GAAP Information."

Financial Highlights for the Second Quarter of 2011

  • Net revenues were $42.8 million for the second quarter of 2011 compared to $41.7 million for the first quarter of 2011 and $29.1 million a year ago.  Revenues from our German operations were $20.3 million in the second quarter of 2011, compared to $18.9 million in the first quarter of 2011 and $5.7 million a year ago, which comprised only the month of June.

  • GAAP gross margin percentage was 37.4% in the second quarter of 2011 compared to 44.2% for the first quarter of 2011 and 54.4% a year ago.  Non-GAAP gross margin percentage was 42.0% in the second quarter of 2011 compared to 48.7%
    '/>"/>

  • SOURCE ERT
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    2. Spherix Reports Second Quarter Earnings
    3. Tapestry Reports Second Quarter 2007 Results
    4. Callisto Reports on Second-Quarter 2007 Milestones
    5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    9. Biopure Reports on Meeting with the FDA
    10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
    11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... , September 19, 2014 ... IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt ... interaktive PDF, verfügbar unter pharmaserialisation.com , zeigt ... sie jeweils in Kraft treten. Für ... nicht länger um das "ob", sondern darum, "wann" ...
    (Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
    (Date:9/19/2014)... Mass. , Sept. 19, 2014   Personal ... advanced cancer genome analysis and testing services, and ... and developing highly selective kinase inhibitors for genomically ... study of malignant mixed Mullerian tumors (MMMT), an ... system, also known as carcinosarcoma. The new ...
    Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
    ... 2011 Seal Shield LLC today announced ... for the iPad.  The product has been designed specifically ... use in hospital settings. The Seal Shield ... which is resistant to liquids including blood and bleach. ...
    ... MALVERN, Pa., Feb. 21, 2011 Today, Siemens (NYSE: ... Overhage, MD, PhD, as Chief Medical Informatics Officer (CMIO), of ... of the In diana Health Information Exchange ... this not-for-profit organization. In his role at Siemens, Marc will ...
    Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2
    (Date:9/19/2014)... Food and Drug Administration approved a new type 2 diabetes ... of once-a-week injectable drugs that help manage blood sugar levels ... a new treatment option, which can be used alone or ... in the overall management of type 2 diabetes," Dr. Mary ... II, said in an agency news release. About ...
    (Date:9/19/2014)... 2014 The Alliance for Bangladesh ... the National Fire Protection Association (NFPA), a recognized ... today in a Memorandum of Understanding signed by ... and other stakeholders with information, guidance and access ... health and safety of workers in ready-made garment ...
    (Date:9/19/2014)... September 19, 2014 MetroMD, a leading anti-ageing ... “God Particle” of human health. This therapy has grown tremendously ... the therapy more effective, safe and dependable. It has far ... an opportunity to live a very healthy and active lifestyle ... of HGH therapy, a senior therapist at MetroMD said, “HGH ...
    (Date:9/19/2014)... 2014 "I have difficulty putting in ... to stretching the skin around my eyes during the ... me to design a more convenient method of performing ... provides a quicker, easier, more sanitary method of putting ... this task manually, saves time and effort, and helps ...
    (Date:9/19/2014)... (Sept. 19, 2014) - New research published today in ... Ebola cases could reach 6,800 in West Africa by ... are not enacted. , Arizona State University and ... the rate of rise in cases significantly increased in ... a mass quarantine was put in place, indicating that ...
    Breaking Medicine News(10 mins):Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:Research predicts possible 6,800 new Ebola cases this month 2
    ... part of its campaign to be the,leading provider of ... will be hosting "A Matter of Heart" Health Fair ... hear the latest expert,medical advice on heart disease prevention ... staff will also be performing,free cholesterol, carotid bruit, blood ...
    ... baby,s cord blood with M.A.Z.E. Cord Blood Laboratories in Purchase, NY. They ... to have it just in case. , ... Cresskill, NJ ... to bank their baby,s cord blood with M.A.Z.E. Cord Blood ...
    ... Seattle, December 8, 2008 Epileptologists are constantly searching for ... brain down to its most fundamental cellular and molecular detail ... to locate and treat the specific cells, neurons or network ... Another is to restore cognitive function after possible injury from ...
    ... Dr. Timothy McDonald, physician, attorney,and chief safety and risk ... Medical Center, will give the keynote address titled "The Legal ... Association,for Respiratory Care (AARC) International Respiratory Congress at the Anaheim,Convention ... One of the issues ...
    ... malignancies , , TUESDAY, Dec. 9 (HealthDay News) -- An ... bone marrow cancers called myeloproliferative disorders (MPDs), according to ... cells. , The findings were to be presented Tuesday ... Hematology, in San Francisco. , The researchers, from Oregon ...
    ... more commonly known as ,lazy eye, could be drastically ... Nottingham. , Amblyopia is thought to affect up to 2.5 ... cent of all children,s eye appointments in the UK. Occlusion ... ,train, the affected eye is the main treatment for ...
    Cached Medicine News:Health News:Estero Urgent Care to Hold 'A Matter Of Heart' Health Fair, a Free Event Focusing on Heart Disease Prevention to be Held on December 21st at Estero Community Park 2Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 2Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 4Health News:Researchers report on convergence of technology 2Health News:'A Principled Approach to Medical Mistakes' To Be Addressed at 54th Annual International Congress for Respiratory Therapists 2Health News:'A Principled Approach to Medical Mistakes' To Be Addressed at 54th Annual International Congress for Respiratory Therapists 3Health News:Lazy eye treatment times could be drastically reduced, new research shows 2
    Inquire...
    ... are accurate to 1 mm. In vivo results ... patients encapsulation scar tissue. Encapsulation scar tissue can ... therefore actual projection may vary from patient to ... surgeon with a scalpel or surgical scissors. All ...
    ... IQmarkTM Diagnostic Workstation Software offers a ... that digitally stores many different diagnostic ... Microsofts open-architecture products in mind, our ... integration (using ActiveX controls), networking, central ...
    ... engineered to set a new standard for ... enter the patient demographics, select auto report ... based system uses the latest in software ... of the IQmark Holter algorithm. Simple, intuitive ...
    Medicine Products: